What type(s) of vaccine is/are available?
On August 31st, 2022, the US Food and Drug Administration (FDA) deauthorized the use of monovalent Moderna and Pfizer COVID-19 vaccines for booster administration. Due to this change, we will no longer be administering the monovalent COVID-19 vaccine.
The Moderna COVID-19 Vaccine, Bivalent, is now recommended and authorized for the emergency use as a single booster dose in individuals 6 years of age and older under an Emergency Use Authorization (EUA). The new formulation contains components of the more recent COVID-19 strains and should be administered at least two months following previous primary or booster vaccination.